Winslow Evans & Crocker’s Nuveen Corporate Income November 2021 Target Term Fund JHB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$0 Sell
34,627
-9,655
-22% -$88K ﹤0.01% 1378
2020
Q3
$396K Buy
44,282
+1,035
+2% +$9.4K 0.1% 197
2020
Q2
$386K Sell
43,247
-5,293
-11% -$46.7K 0.1% 191
2020
Q1
$418K Buy
48,540
+412
+0.9% +$3.95K 0.14% 152
2019
Q4
$482K Sell
48,128
-1,204
-2% -$12K 0.12% 177
2019
Q3
$488K Buy
49,332
+1,014
+2% +$10.1K 0.14% 165
2019
Q2
$480K Buy
48,318
+4,626
+11% +$45.5K 0.13% 171
2019
Q1
$428K Buy
43,692
+12,492
+40% +$121K 0.12% 179
2018
Q4
$278K Buy
+31,200
New +$293K 0.09% 216

Other funds holding JHB

Winslow Evans & Crocker's JHB Position: Q4 2020 in Review

Winslow Evans & Crocker reduced its Nuveen Corporate Income November 2021 Target Term Fund (JHB) stake by 22% in Q4 2020, selling an estimated $88K and leaving 34,627 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1378.

Winslow Evans & Crocker first reported a position in JHB in Q4 2018 and has held it in 9 quarters since. The position peaked at $488K in Q3 2019. 52 funds tracked by Wall St. Rank hold JHB as of Q4 2020.

  • Winslow Evans & Crocker held 34,627 shares of Nuveen Corporate Income November 2021 Target Term Fund worth $0 as of Q4 2020.
  • Winslow Evans & Crocker sold 9,655 Nuveen Corporate Income November 2021 Target Term Fund shares in Q4 2020, an estimated $88K.
  • Nuveen Corporate Income November 2021 Target Term Fund made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1378 holding.
  • Winslow Evans & Crocker first reported a position in Nuveen Corporate Income November 2021 Target Term Fund in Q4 2018 and has held it in 9 quarters since.
  • Winslow Evans & Crocker's Nuveen Corporate Income November 2021 Target Term Fund position peaked at $488K in Q3 2019.
  • 52 funds tracked by Wall St. Rank held Nuveen Corporate Income November 2021 Target Term Fund as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.